Ajmaline

DRUG4 trials

Sponsors

Hospital Clinic of Barcelona, IRCCS Policlinico S. Donato, St George's, University of London, Universitair Ziekenhuis Brussel

Conditions

Atrial FibrillationBrugada SyndromeCardiac DeathChannelopathiesSudden DeathTachycardia, VentricularVentricular Fibrillation

Phase 2

The Response To Ajmaline Provocation in Healthy Subjects

St George's, University of LondonBrugada Syndrome, Sudden Death

Start: 2017-10-22End: 2019-12-31Target: 100Updated: 2019-11-05

Phase 4

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias

CompletedNCT00702117

Hospital Clinic of BarcelonaAtrial Fibrillation, Brugada Syndrome, Tachycardia, Ventricular

Start: 2008-06-30End: 2010-01-31Updated: 2010-12-15

Unknown Phase

Epicardial Ablation in Brugada Syndrome

CompletedNCT02641431

IRCCS Policlinico S. DonatoBrugada Syndrome

Start: 2015-11-16End: 2016-12-30Updated: 2018-01-17

Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial

Universitair Ziekenhuis BrusselBrugada Syndrome, Cardiac Death, Channelopathies +1

Start: 2020-11-16End: 2022-10-31Target: 25Updated: 2021-12-08

Related Papers

Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: clinical implications from a prospective clinical trial

EP Europace2019-10-2126 citations

Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome.

2018-04-0166 citations

Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome

Circulation Arrhythmia and Electrophysiology2017-05-01235 citations